sorafenib has been researched along with amentoflavone in 1 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (amentoflavone) | Trials (amentoflavone) | Recent Studies (post-2010) (amentoflavone) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 217 | 0 | 133 |
| Protein | Taxonomy | sorafenib (IC50) | amentoflavone (IC50) |
|---|---|---|---|
| Mcl-1 | Homo sapiens (human) | 1.6341 | |
| Valosin-containing protein | Homo sapiens (human) | 8.984 | |
| Spike glycoprotein | Betacoronavirus England 1 | 8.3 | |
| Replicase polyprotein 1ab | Betacoronavirus England 1 | 8.3 | |
| hypothetical protein SA1422 | Staphylococcus aureus subsp. aureus N315 | 19.39 | |
| Gamma-aminobutyric acid receptor subunit pi | Rattus norvegicus (Norway rat) | 0.0149 | |
| Transmembrane protease serine 2 | Homo sapiens (human) | 8.3 | |
| Amyloid-beta precursor protein | Homo sapiens (human) | 4.8 | |
| Procathepsin L | Homo sapiens (human) | 8.3 | |
| Neutrophil elastase | Homo sapiens (human) | 1.27 | |
| Poly [ADP-ribose] polymerase 1 | Homo sapiens (human) | 0.1023 | |
| Replicase polyprotein 1a | Severe acute respiratory syndrome-related coronavirus | 8.3 | |
| Replicase polyprotein 1ab | Human coronavirus 229E | 8.3 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | 8.3 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 8.3 | |
| Matrix metalloproteinase-9 | Homo sapiens (human) | 2.58 | |
| Gamma-aminobutyric acid receptor subunit beta-1 | Rattus norvegicus (Norway rat) | 0.0149 | |
| Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | 7.4 | |
| Gamma-aminobutyric acid receptor subunit delta | Rattus norvegicus (Norway rat) | 0.0149 | |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Rattus norvegicus (Norway rat) | 0.0149 | |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Rattus norvegicus (Norway rat) | 0.0149 | |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | 0.0149 | |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Rattus norvegicus (Norway rat) | 0.0149 | |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | 0.0149 | |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | 0.0149 | |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Rattus norvegicus (Norway rat) | 0.0149 | |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Rattus norvegicus (Norway rat) | 0.0149 | |
| Beta-secretase 1 | Homo sapiens (human) | 1.54 | |
| Spike glycoprotein | Severe acute respiratory syndrome-related coronavirus | 8.3 | |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 0.0149 | |
| Gamma-aminobutyric acid receptor subunit beta-3 | Rattus norvegicus (Norway rat) | 0.0149 | |
| Gamma-aminobutyric acid receptor subunit beta-2 | Rattus norvegicus (Norway rat) | 0.0149 | |
| GABA theta subunit | Rattus norvegicus (Norway rat) | 0.0149 | |
| Angiotensin-converting enzyme 2 | Homo sapiens (human) | 8.3 | |
| Gamma-aminobutyric acid receptor subunit epsilon | Rattus norvegicus (Norway rat) | 0.0149 | |
| M1-family alanyl aminopeptidase | Plasmodium falciparum 3D7 | 108.39 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, CW; Hsu, FT; Kuo, YC; Pan, PJ; Tsai, JJ | 1 |
1 other study(ies) available for sorafenib and amentoflavone
| Article | Year |
|---|---|
Amentoflavone Enhances the Therapeutic Efficacy of Sorafenib by Inhibiting Anti-apoptotic Potential and Potentiating Apoptosis in Hepatocellular Carcinoma
Topics: Animals; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Biflavonoids; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Synergism; Humans; Liver Neoplasms; Mice; Mice, Nude; Niacinamide; Phenylurea Compounds; Sorafenib; Xenograft Model Antitumor Assays | 2018 |